HARMONi-2 Trial Results Transforming NSCLC

By Rene Pretorius

October 18, 2024

The findings of the HARMONi-2 trial could significantly change how NSCLC is treated, particularly if the promising results are validated in future studies. Here are the key points: Trial Overview The HARMONi-2 trial compared ivonescimab...

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.